Effect of Sex, Use of Pantoprazole and Polymorphisms in SLC22A1, ABCB1, CES1, CYP3A5 and CYP2D6 on the Pharmacokinetics and Safety of Dabigatran
Pablo Zubiaur, Miriam Saiz‐Rodríguez, Dolores Ochoa, Marcos Navares‐Gómez, Gina Mejía‐Abril, Manuel Román, Dóra Koller, Paula Soria‐Chacartegui, Susana Almenara, Francisco Abad‐Santos
Topics & Concepts
MedicinePantoprazolePharmacokineticsCYP2D6DabigatranInternal medicinePharmacologyWarfarinAtrial fibrillationCytochrome P450OmeprazoleMetabolismPharmacogenetics and Drug MetabolismAtrial Fibrillation Management and OutcomesAntiplatelet Therapy and Cardiovascular Diseases